Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets.

TitleRetinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets.
Publication TypeJournal Article
Year of Publication2012
AuthorsDal Col J, Mastorci K, Faè DAntonia, Muraro E, Martorelli D, Inghirami G, Dolcetti R
JournalCancer Res
Volume72
Issue7
Pagination1825-35
Date Published2012 Apr 01
ISSN1538-7445
KeywordsAged, Alitretinoin, Antineoplastic Combined Chemotherapy Protocols, Apoptosis, Cell Line, Tumor, Cell Proliferation, Female, Forkhead Box Protein O3, Forkhead Transcription Factors, Humans, Interferon-alpha, Lymphoma, Mantle-Cell, Male, Middle Aged, Phosphoinositide-3 Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Proto-Oncogene Proteins c-bcl-2, Receptors, Retinoic Acid, Retinoic Acid Receptor alpha, Retinoid X Receptors, Tretinoin
Abstract

Mantle cell lymphoma (MCL) is characterized by a profound deregulation of the mechanisms controlling cell-cycle progression and survival. We herein show that the combination of 9-cis-retinoic acid (RA) and IFN-α induces marked antiproliferative and proapoptotic effects in MCL cells through the modulation of critical targets. Particularly, IFN-α enhances RA-mediated G(0)-G(1) cell accumulation by downregulating cyclin D1 and increasing p27(Kip1) and p21(WAF1/Cip1) protein levels. Furthermore, RA/IFN-α combination also induces apoptosis by triggering both caspases-8 and -9 resulting in Bax and Bak activation. In particular, RA/IFN-α treatment downregulates the antiapoptotic Bcl-xL and Bfl-1 proteins and upregulates the proapoptotic BH3-only Noxa protein. Sequestration of Mcl-1 and Bfl-1 by upregulated Noxa results in the activation of Bid, and the consequent induction of apoptosis is inhibited by Noxa silencing. Noxa upregulation is associated with nuclear translocation of the FOXO3a transcription factor as consequence of RA/IFN-α-induced Akt inhibition. Pharmacologic suppression of Akt, but not of TORC1, increases Noxa protein levels and downregulates Bfl-1 protein supporting the conclusion that the inhibition of the Akt pathway, the resulting FOXO3a activation and Noxa upregulation are critical molecular mechanisms underlying RA/IFN-α-dependent MCL cell apoptosis. These results support the potential therapeutic value of RA/IFN-α combination in MCL management.

DOI10.1158/0008-5472.CAN-11-2505
Alternate JournalCancer Res
PubMed ID22311672
Related Faculty: 
Giorgio Inghirami, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700